Steve Bossone

Dr. Bossone joined Alnylam 2010 from Shire HGT with over 15 years of experience in the biotech industry. As a Senior Patent Attorney at Shire he provided licensing, acquisition and litigation support as well as strategic input into the life cycle management of several marketed products. Steve began his career at Millennium Pharmaceuticals as a Scientist in the oncology group and then at Millennium Biotherapeutics where he headed the transcript profiling group to support drug discovery initiatives. He transitioned to the Intellectual Property field with positions of increasing authority at Millennium, ToleRx, Serono and Shire. He received his PhD in Molecular Pathology from the lab of Dr. Kenneth Marcu at SUNY Stony Brook (NY) and subsequently worked as a Research Fellow in Medicine in the lab of Dr. Vikas Sukhatme at Harvard Medical School and Beth Israel Hospital. Steve received his JD from Suffolk University School of Law.

Steve Bossone is the Senior Vice President, Chief Patent Counsel at Alnylam Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Steve Bossone has a rich history of leadership and innovation.Steve Bossone studied JD Intellectual Property at Suffolk University Law School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.